Sign In
Buy APPN
$20.51
+0.640 (+3.22%)
At Close: Jun 23, 2026
Appian Doubles Down on Market Expansion
01:08pm, Sunday, 08'th May 2022 The Motley Fool
The low-code software company is tapping into new ways to grow its business.
Appian Doubles Down on Market Expansion
09:08am, Sunday, 08'th May 2022
The low-code software company is tapping into new ways to grow its business.
Why Appian Stock Topped the Market Today
09:40pm, Friday, 06'th May 2022 The Motley Fool
There's nothing like a pair of quarterly beats to make shareholders happy.
Why Appian Stock Topped the Market Today
05:40pm, Friday, 06'th May 2022
There's nothing like a pair of quarterly beats to make shareholders happy.
Appian (APPN) Q1 2022 Earnings Call Transcript
04:30am, Friday, 06'th May 2022 The Motley Fool
APPN earnings call for the period ending March 31, 2022.
Appian (APPN) Reports Q1 Loss, Tops Revenue Estimates
10:15pm, Thursday, 05'th May 2022 Zacks Investment Research
Appian (APPN) delivered earnings and revenue surprises of 57.14% and 7.19%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?
Appian Corporation's (APPN) CEO Matt Calkins on Q1 2022 Results - Earnings Call Transcript
07:38pm, Thursday, 05'th May 2022
Appian Corporation (NASDAQ:APPN ) Q1 2022 Earnings Conference Call May 5, 2022 4:30 PM ET Company Participants Sri Anantha – Director of Investor Relations Matt Calkins – Chairman and Chief Execut
Executives Buy Over $373M Of 4 Stocks
11:52am, Thursday, 05'th May 2022 Benzinga
Although crude oil futures traded higher on Thursday, there were a few notable insider trades.
When insiders purchase shares, it indicates their confidence in the company's prospects or that they view
These stocks soared during the pandemic, and then crashed. Ten are now expected to double in price.
11:00am, Wednesday, 04'th May 2022 MarketWatch
The group rose at least 300% in the pandemic before crashing 70% or more.
Benzinga's Top Ratings Upgrades, Downgrades For April 27, 2022
02:02pm, Wednesday, 27'th Apr 2022 Benzinga
Upgrades
BTIG upgraded the previous rating for Acutus Medical Inc (NASDAQ:AFIB) from Neutral to Buy. In the fourth quarter, Acutus Medical showed an EPS of $1.00, compared to $0.89 from the year-ago
2 Growth Stocks Down More Than 75% to Buy Now and Hold
03:34pm, Tuesday, 19'th Apr 2022 The Motley Fool
Buying these down-but-not-out growth stocks could supercharge your portfolio.
2 Growth Stocks Down More Than 75% to Buy Now and Hold
11:34am, Tuesday, 19'th Apr 2022
Buying these down-but-not-out growth stocks could supercharge your portfolio.
Appian To Announce First Quarter 2022 Financial Results on May 5
08:50pm, Monday, 18'th Apr 2022 GlobeNewswire Inc.
MCLEAN, Va., April 18, 2022 (GLOBE NEWSWIRE) -- Appian (NASDAQ: APPN) today announced that it will release financial results for the first quarter ended March 31, 2022 following the close of market
Banning software sales to Russia, 'Is an obvious case of good and evil,' Appian CEO says
04:56pm, Monday, 18'th Apr 2022
Appian CEO Matt Calkins explains why he's calling for a permanent ban on software sales to 'Putin's Russia' amid the country's war with Ukraine.
Appian To Announce First Quarter 2022 Financial Results on May 5
04:50pm, Monday, 18'th Apr 2022
MCLEAN, Va., April 18, 2022 (GLOBE NEWSWIRE) -- Appian (NASDAQ: APPN) today announced that it will release financial results for the first quarter ended March 31, 2022 following the close of market
